¼¼°èÀÇ °¢°á¸·¿° ½ÃÀå ±Ô¸ð Á¶»ç : ¾àÁ¦ Ŭ·¡½ºº°, Åõ¿© °æ·Îº°, ÃÖÁ¾»ç¿ëÀÚº°, À¯Åë ä³Îº°, Áö¿ªº°, ¿¹Ãø(2022-2032³â)
Global Keratoconjunctivitis Market Size study, by Drug Class, by Route of Administration, by End-Users, by Distribution Channel and Regional Forecasts 2022-2032
»óǰÄÚµå : 1579943
¸®¼­Ä¡»ç : Bizwit Research & Consulting LLP
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 285 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 7,162,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,250 £Ü 9,043,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ °¢°á¸·¿° ½ÃÀåÀº 2023³â¿¡ ¾à 4¾ï 7,246¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£2024-2032³â¿¡´Â 5.31% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

°¢°á¸·¿°Àº °¢¸·°ú °á¸· ¸ðµÎ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿°Áõ¼º ÁúȯÀ¸·Î º¸Åë °¨¿°, ¾Ë·¹¸£±â, ȯ°æ Àڱؿ¡ ÀÇÇØ ¹ß»ýÇÕ´Ï´Ù. °¢°á¸·¿°Àº ¹ÙÀÌ·¯½º¼º, ¼¼±Õ¼º, ¾Ë·¹¸£±â¼º, ¾È±¸°ÇÁ¶Áõ µî ´Ù¾çÇÑ À¯ÇüÀÌ ÀÖ½À´Ï´Ù. ÀϹÝÀûÀÎ Áõ»óÀ¸·Î´Â ÃæÇ÷, °¡·Á¿òÁõ, ´«°ö µîÀÌ ÀÖÀ¸¸ç, ÀÌ´Â ´« Ç¥¸é¿¡ ¿°ÁõÀÌ ¹ß»ýÇßÀ½À» ³ªÅ¸³À´Ï´Ù. ƯÈ÷ µµ½Ã Áö¿ª¿¡¼­ ¾Ë·¹¸£±â ¹× ȯ°æÀû ¿äÀÎÀÇ À¯º´·üÀÌ Áõ°¡Çϸ鼭 °¢°á¸·¿° ½ÃÀåÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °íÇØ»óµµ ¾È±¸ Ç¥¸é À̹Ì¡ ¹× ´«¹° ºÐÇØ ½Ã°£ ºÐ¼®±â¿Í °°Àº ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ ±â¼ú ¹ßÀüÀ¸·Î Áø´Ü Á¤È®µµ°¡ Å©°Ô Çâ»óµÇ¾î Ä¡·á °á°ú °³¼±¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ȯÀÚ Ä¡·á¸¦ °³¼±Çϰí È¿°úÀûÀÎ °¢°á¸·¿° Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ Áö¿øÇϸ鼭 ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä µ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¼¼°è °¢°á¸·¿° ½ÃÀåÀº ¼Ò¸Å ¾à±¹À» ÅëÇÑ Ä¡·áÁ¦ÀÇ Á¢±Ù¼º Çâ»ó°ú ¼±Áø±¹ÀÇ ¼Ò¸Å ¾à±¹ È®´ë¿¡ ÈûÀÔ¾î Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼Ò¸Å ¾à±¹µéÀº °¢°á¸·¿°¿¡ ´ëÇÑ ´Ù¾çÇÑ ÀϹÝÀǾàǰ ¹× ó¹æÀü Ä¡·áÁ¦¸¦ Á¦°øÇÔÀ¸·Î½á º¸´Ù Æí¸®Çϰí Á¢±ÙÇϱ⠽¬¿î ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ºÎÀÀÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå °³¹ßÀº ó¹æµÈ Ä¡·á¹ý¿¡ ´ëÇÑ È¯ÀÚÀÇ ¼øÀÀµµ¸¦ Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó Å« ½ÃÀå ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª Ç×»ýÁ¦ °ú´Ù »ç¿ëÀ¸·Î ÀÎÇÑ Ç×»ýÁ¦ ³»¼º±Õ Áõ°¡¿Í °°Àº ¹®Á¦¿¡ Á÷¸éÇØ ÀÖÀ¸¸ç, ÀÌ´Â Ä¡·á¸¦ º¹ÀâÇÏ°Ô ¸¸µé°í ÀÇ·áºñ¿ëÀ» Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Æ¯È÷ »çÇ϶ó »ç¸· À̳² ¾ÆÇÁ¸®Ä«¿Í °°Àº Áö¿ª¿¡¼­´Â ¼÷·ÃµÈ ¾È°ú Àǻ簡 ºÎÁ·ÇÏ¿© °í±Þ Áø´Ü Åø¿Í Ä¡·á¹ýÀÇ È¿°úÀûÀÎ »ç¿ëÀÌ Á¦ÇÑµÇ¾î ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù.

¼¼°èÀÇ °¢°á¸·¿° ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¹× ±âŸ Áö¿ªÀÔ´Ï´Ù. ºÏ¹Ì´Â ¼¼°è °¢°á¸·¿° ½ÃÀå¿¡¼­ ¼öÀͼº Ãø¸é¿¡¼­ ¿ìÀ§¸¦ Á¡Çϰí ÀÖ´Â Áö¿ªÀÔ´Ï´Ù. ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀº Çõ½ÅÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä, ¸¹Àº ȯÀÚ ¼ö, À¯¸®ÇÑ »óȯ Á¤Ã¥ µîÀÇ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç´Â ÀÌ Áö¿ª ½ÃÀå ÁöÀ§¸¦ ´õ¿í °­È­½Ã۰í ÀÖ½À´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº °¢°á¸·¿°¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÀÇ·á ÀÎÇÁ¶ó È®´ë, Áß±¹ ¹× Àεµ¿Í °°Àº Àα¸ ¹ÐÁý ±¹°¡¿¡¼­ÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ °¢°á¸·¿° ½ÃÀå : °³¿ä

Á¦2Àå ¼¼°èÀÇ °¢°á¸·¿° ½ÃÀå Á¤ÀÇ¿Í Á¶»ç ÀüÁ¦Á¶°Ç

Á¦3Àå ¼¼°èÀÇ °¢°á¸·¿° ½ÃÀå ¿ªÇÐ

Á¦4Àå ¼¼°èÀÇ °¢°á¸·¿° ½ÃÀå : »ê¾÷ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ °¢°á¸·¿° ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ¾àÁ¦ Ŭ·¡½ºº°, 2022-2032³â

Á¦6Àå ¼¼°èÀÇ °¢°á¸·¿° ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Åõ¿© °æ·Îº°, 2022-2032³â

Á¦7Àå ¼¼°èÀÇ °¢°á¸·¿° ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2022-2032³â

Á¦8Àå ¼¼°èÀÇ °¢°á¸·¿° ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Åë ä³Îº°, 2022-2032³â

Á¦9Àå ¼¼°èÀÇ °¢°á¸·¿° ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°, 2022-2032³â

Á¦10Àå °æÀï Á¤º¸

Á¦11Àå Á¶»ç ÇÁ·Î¼¼½º

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Keratoconjunctivitis Market is valued at approximately USD 472.46 Million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.31% over the forecast period 2024-2032. Keratoconjunctivitis is an inflammatory condition that affects both the cornea and conjunctiva, typically arising from infections, allergies, or environmental irritants. It encompasses various forms, such as viral, bacterial, allergic, and dry eye-related keratoconjunctivitis. Common symptoms include redness, itching, and discharge, indicative of the inflammation impacting the eye's surface. The increasing prevalence of allergies and environmental factors, particularly in urbanized regions, is fueling the growth of the keratoconjunctivitis market. Additionally, technological advancements in biotechnology, such as high-resolution ocular surface imaging and tear break-up time analyzers, have significantly enhanced diagnostic accuracy, contributing to improved treatment outcomes. These advancements are key drivers of the market's growth, as they improve patient care and support the rising demand for effective keratoconjunctivitis treatments.

The Global Keratoconjunctivitis Market is poised for significant growth, driven by the increasing availability of treatments through retail pharmacies and the expansion of these outlets in developed regions. Retail pharmacies are responding to the growing demand for accessible and convenient healthcare solutions by offering a wider range of over-the-counter and prescription treatments for keratoconjunctivitis. This development not only enhances patient adherence to prescribed treatments but also opens up substantial market opportunities. However, the market faces challenges such as the rising incidence of antibiotic-resistant bacterial strains due to the overuse of antibiotics, which complicates treatment and drives up healthcare costs. Moreover, a shortage of skilled ophthalmologists, especially in regions like sub-Saharan Africa, limits the effective use of advanced diagnostic tools and therapies, constraining market growth.

The key regions considered for the Global Keratoconjunctivitis Market study include Asia Pacific, North America, Europe, Latin America, Middle East & Africa, and Rest of the World. North America is a dominating region in the Global Keratoconjunctivitis Market in terms of revenue. The market growth in the region is being attributed to factors including strong demand for innovative therapies, a large patient population, and favorable reimbursement policies. The presence of key market players further strengthens the region's market position. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by increasing awareness of keratoconjunctivitis, expanding healthcare infrastructure, and a rising prevalence of the condition in densely populated countries such as China and India.

Major market players included in this report are:

The detailed segments and sub-segment of the market are explained below:

By Drug Class

By Route of Administration

By End-Users

By Distribution Channel

By Region:

Years considered for the study are as follows:

Key Takeaways:

Table of Contents

Chapter 1. Global Keratoconjunctivitis Market Executive Summary

Chapter 2. Global Keratoconjunctivitis Market Definition and Research Assumptions

Chapter 3. Global Keratoconjunctivitis Market Dynamics

Chapter 4. Global Keratoconjunctivitis Market Industry Analysis

Chapter 5. Global Keratoconjunctivitis Market Size & Forecasts by Drug Class 2022-2032

Chapter 6. Global Keratoconjunctivitis Market Size & Forecasts by Route of Administration 2022-2032

Chapter 7. Global Keratoconjunctivitis Market Size & Forecasts by End-Users 2022-2032

Chapter 8. Global Keratoconjunctivitis Market Size & Forecasts by Distribution Channel 2022-2032

Chapter 9. Global Keratoconjunctivitis Market Size & Forecasts by Region 2022-2032

Chapter 10. Competitive Intelligence

Chapter 11. Research Process

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â